ArticleBMC medical research methodology2025
A database to initiate methodological advances in the evaluation of transitivity assumption in network meta-analysis: qualitative features and limitations of the tracenma R package.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A database to initiate methodological advances in the evaluation of transitivity assumption in network meta-analysis: qualitative features and limitations of the tracenma R package.BMC medical research methodology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTransitivity assumption underlies the network meta-analysis framework and states that treatment comparisons are similar regarding the distribution of important characteristics that act as effect modifiers. Currently, there is a lack of methods to assess transitivity quantitatively. The methodological gap in assessing the transitivity assumption motivated the development of the tracenma database, aspiring to initiate methodological advances in transitivity assessment using empirical data.
methodsWe used the nmadb R package to build a database of connected networks and consulted the relevant literature to determine the necessary characteristics comprising potential effect modifiers. We referred to the systematic review report and supplementary material for each eligible network to retrieve at least four extractable characteristics. The extracted information comprised the studies, corresponding treatment comparisons, and aggregated characteristics at the study level. We classified the characteristics into three types (clinical, demographic and methodological) and ten subtypes (participants, treatments, outcomes, age, sex, ethnicity, study design, study setting, risk of bias and withdrawals). We summarised the distribution of the characteristics and missing data across all datasets by type and subtype.
resultsOf the 453 networks in the nmadb database, 217 (48%) were eligible for the tracenma database, with each network comprising a dataset. The extracted characteristics ranged from 4 to 35 (median: 11), with the middle half comprising 8 to 15 characteristics. In most datasets, some characteristics were transformed for being reported inconsistently across the studies concerning the measure scale and summary statistics. Methodological characteristics dominated all datasets and were less prone to missing data. The study design was ubiquitous among the methodological subtypes, while withdrawals were hardly reported. Clinical characteristics were present in most datasets and were subject to most missing data; their characteristic subtypes received uneven attention, with participant characteristics reported more frequently. Demographic characteristics were the least frequently reported. Seventy per cent of the datasets included all types; however, the characteristic subtypes varied substantially in frequency.
conclusionsTracenma is the first database built to motivate the development and empirical evaluation of novel methods for assessing transitivity. The database is hosted in the tracenma R package with functions that facilitate data access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.